terminal alkynes to 5-iodo- or 5-triflate esters of 2-deoxyuridine (Figure 3.27). Coupling with allylamine
or propargylamine (Figure 3.27c) allows the functionalization of 2-deoxyuridine or its 5-triphosphate with
nucleophilic amino groups that allow further elaboration of the nucleoside through reaction with N-hydrox-
ysuccinimidyl esters. Examples include coupling with carboxylic acids of compounds such as imidazole for
use in SELEX64,65(Section 5.7.3), or in the preparation of 2,3-dideoxy-UTP analogues labelled with, for exam-
ple, biotin or fluorescein,2,66,67the latter finding application in dideoxy DNA sequencing (Section 5.1).
In a number of cases, a minor, fluorescent bicyclic furanopyrimidine has been isolated during Sonogashira
coupling reactions involving 5-iodo-2-deoxyuridine, which takes place in the presence of CuI. This latter
94 Chapter 3
HO OHONNHOOCF 3 SO 2 OHO OHONNHOOHHO OHONNHOORRHHO OHONNHOOIHO OHONNHOOXHX HO OHONNOOXHO OHONNHOOIH
NHCOCF 3HO OHONNHOOCF 3 CONHHO OHONNHOOIHO OHONNOO(CH 2 ) 9 ORHOR(CH 2 ) 9HO OHONNHOO(CH 2 ) 9ROHO OHONNOOCF 3 CONH
OHONNHOOH 2 NO 9 P 3 Ob(i) (i), (ii)R = HOMe 2 C, Ph, 4-MeOC 6 H 4 -,
4-CF 3 C 6 H 4 , 4-F-C 6 H 5R = TMS(i)X = H, Me,
Br or Cl(i)(iv) (v)R = C 4 H 9 , C 5 H 11 , (CH 2 ) 4 Clminorminor4(iii)acd++ +major+
++Figure 3.27 Palladium-catalysed coupling reactions as routes to C-5-substituted pyrimidine nucleosides. Reagents:
(i) Pd(PPh 3 ) 4 , CuI, Et 3 N, DMF; (ii) TBAF, MeOH; (iii) synthesis of triphosphate then NH 4 OH;
(iv) Pd(PPh 3 ) 4 , CuI, i-Pr 2 EtN, DMF; and (v) CuI, Et 3 N, MeOH, heat